Navigation Links
ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO

he power of genomics for target discovery and validation, and in clinical trials to develop more individualized therapeutic outcomes. ChemGenex’s lead compound, Ceflatonin®, is currently in phase 2/3 clinical trials for chronic myeloid leukemia (CML) and Quinamed® is in phase 2 clinical development for prostate, breast and ovarian cancers. The company has a significant portfolio of anti-cancer, diabetes and obesity programs, several of which have been partnered with international pharmaceutical companies. ChemGenex currently trades on the Australian Stock Exchange under the symbol "CXS" and on NASDAQ under the symbol "CXSP".

Contacts
Dr. Greg Collier (CEO and Managing Director) Australia +61 3 5227 2752
USA +1 650 474 9800
Dr. Dennis Brown (President and Director) USA +1 650 474 9800
Australia +61 3 5227 2703

Safe Harbor Statement
Certain statements made herein that use the words “estimate”, “project”, “intend”, “expect”, “believe”, and similar expressions are intended to identify forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties which could cause the actual results, performance or achievements of the company to be materially different from those which may be expressed or implied by such statements, including, among others, risks or uncertainties associated with the development of the company’s technology, the ability to successfully market products in the clinical pipeline, the ability to advance promising therapeutics through clinical trials, the ability to establish our fully integrated technologies, the ability to enter into additional collaborations and strategic alliances and expand current collaborations and obtain milestone payments, the suitability of internally discovered genes for drug development
'"/>




Page: 1 2 3 4

Related medicine technology :

1. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
2. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
3. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
4. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
5. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
6. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
7. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
8. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
9. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
10. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
11. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
Post Your Comments:
(Date:8/28/2015)... , Aug. 28, 2015  Perrigo Company plc ("Perrigo") ... has completed the acquisition of leading OTC brands from ... million. The transaction is a clear demonstration of Perrigo,s ... leading European distribution network spanning 36 countries.  ... Papa commented, "We are excited to complete this ...
(Date:8/28/2015)... PITTSBURGH , Aug. 28, 2015  Mylan ... its shareholders have approved Mylan,s proposed acquisition of ... and the related issuance of Mylan ordinary shares ... of shareholders held today. The transaction received the ... general meeting. In addition, the transaction received support ...
(Date:8/28/2015)... 28, 2015 The report "Eubiotics Market by Type ... Ruminant, and Aquaculture), & by Region ( North America ... , and Rest of the World) - Global Trends ... for Eubiotics was valued at USD 4.62 Billion in 2014 ... at a CAGR of 7.4% from 2015 to 2020. ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5
(Date:8/30/2015)... ... 30, 2015 , ... Natural Rest contains a unique mixture of vitamins and ... remedies, which help to improve mood disorders and anxiety. Like all other Creative Medical ... the field of regenerative medicine conducted by Dr. Amit Patel of the University of ...
(Date:8/30/2015)... Fl (PRWEB) , ... August 30, 2015 , ... ... Kathleen Kall has been promoted from Administrative assistant to Executive Assistant to CEO ... interact with a proven professional, focused on your goals. Kathleen graduated from ...
(Date:8/29/2015)... ... ... On September 30, 2015, the Career and Transfer Center (CTC) at Estrella ... Colleges , will be hosting a Job Expo to provide a professional, open venue ... Expo has expanded to much more than just a typical job and career fair. ...
(Date:8/29/2015)... , ... August 29, 2015 , ... ... of two inventors from Miller Place, N.Y. "I specialize in manual therapy, and ... In addition, it can be used for additional muscle dysfunction throughout the body." ...
(Date:8/29/2015)... ... 29, 2015 , ... Dr. Tim Novelli, DC., Founder and President of the ... acceptance of the chiropractic field in the military. All too often VA hospitals treat ... was made available to the VA program over a decade ago, the reality is ...
Breaking Medicine News(10 mins):Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2
... not part of ... ... Abbott Laboratories (NYSE: ABT ) and Watson,Pharmaceuticals (NYSE: WPI ... price (AWP) litigation filed in 2002 by consumers,and insurance companies, which ...
... 7 The U.S. Agency for,International Development and ... honored guests at an International Women,s Day,celebration today. ... the advancement of women throughout the world and ... day also serves as a reminder,of the continued ...
... for $1 with every prescription ... ... Kmart Pharmacy today,announced the launch of the American Fare Dollar Program, ... proprietary American Fare brand for only $1 with every prescription,purchase., ...
... Kindred Healthcare Trying to Weaken Caregivers, Oppose Quality,Improvements, ... workers,will hold a press conference outside of the ... nursing home chain,s attempts to,weaken its employees and ... a new contract is scheduled to begin., ...
... 7 Following the dramatic suicide of,a student before ... the national children,s crisis charity KidsPeace released tips,for parents ... of youth,suicide, and provide a free resource to local ... out problems... before they become dangerous., Suicide is ...
... Findings may explain why breast-fed infants less likely to be ... mix of bacteria in a baby,s gut may predict whether ... a new study suggests. , Babies with high numbers of ... be protected from excess weight gain, according to a team ...
Cached Medicine News:Health News:Hagens Berman: Eleven Defendants Settle in Average Wholesale Price Litigation 2Health News:Hagens Berman: Eleven Defendants Settle in Average Wholesale Price Litigation 3Health News:First Lady Honors Women at International Women's Day Event 2Health News:Kmart Pharmacy to Launch First $1 OTC Program 2Health News:UHW to Nursing Home Chain: Stop Undermining Workers 2Health News:Following School Suicide, National Children's Charity Issues Tips and Free Resources to Help Prevent 3rd Leading Cause of Death Among Youth 2Health News:Following School Suicide, National Children's Charity Issues Tips and Free Resources to Help Prevent 3rd Leading Cause of Death Among Youth 3Health News:Following School Suicide, National Children's Charity Issues Tips and Free Resources to Help Prevent 3rd Leading Cause of Death Among Youth 4Health News:Bacteria Mix in Guts of Babies Predicts Obesity 2Health News:Bacteria Mix in Guts of Babies Predicts Obesity 3
... 1027, with a Carbon Fiber Top, ... for superior C-arm access, safety and ... means C-Arm utilization is quick and ... is minimized resulting in a safer ...
A simple to use system which is both economical and ecologically friendly....
... The Amsco 3085 SP Surgical Table combines ... for patients weighing up to 1,000 lbs. ... patients in both normal and reverse orientation ... as with other patients.,The Amsco 3085 SP ...
... play an important part in our daily ... rheumatic changes can cause severe handicaps. A ... finger-joint prostheses was to produce a reconstructed ... function as nearly possible.,The cementless RM Finger ...
Medicine Products: